Context Therapeutics
CNTX
CNTX
24 hedge funds and large institutions have $4.02M invested in Context Therapeutics in 2023 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 7 increasing their positions, 1 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more ownership
Funds ownership: →
more funds holding
Funds holding: →
3% more capital invested
Capital invested by funds: $3.89M → $4.02M (+$127K)
Holders
24
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$1.1M | |
| 2 | +$10.7K | |
| 3 | +$6.15K | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$2.85K |
| 5 |
Renaissance Technologies
New York
|
+$2.35K |